Inozyme Pharma Inc. (INZY)

NASDAQ: INZY · Real-Time Price · USD

1.64

0.43 (35.54%)

At close: May 02, 2025, 3:59 PM

1.63

-0.31%

After-hours: May 02, 2025, 05:58 PM EDT

Inozyme Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	21.08M	34.59M	32.91M	23.32M	159.9M	31.61M	35.97M
Short-Term Investments	92.01M	154M	94.95M	88.48M	119.66M	15.53M	7.2M
Long-Term Investments	n/a	n/a	354K	354K	12.2M	130K	n/a
Other Long-Term Assets	1.16M	2M	3.81M	3.41M	3.54M	56K	34K
Receivables	n/a	385K	115K	62K	155K	104K	31K
Inventory	n/a	n/a	-115K	-62K	-12.35M	n/a	n/a
Other Current Assets	311K	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	120.68M	196.25M	131.39M	115.34M	150.98M	47.46M	43.27M
Property-Plant & Equipment	1.35M	2.59M	3.64M	4.44M	2.65M	298K	242K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.51M	4.6M	7.8M	8.2M	18.38M	484K	276K
Total Assets	123.18M	200.85M	139.19M	123.54M	169.36M	47.94M	43.54M
Account Payables	2.53M	1.17M	2.54M	2.39M	3.07M	901K	984K
Deferred Revenue	n/a	n/a	3.81M	n/a	279K	n/a	n/a
Short-Term Debt	15.41M	n/a	816K	731K	n/a	n/a	n/a
Other Current Liabilities	15.95M	8.77M	7.74M	5.4M	279K	1.47M	576K
Total Current Liabilities	33.9M	14.69M	14.71M	11.63M	9.97M	3.24M	2.39M
Long-Term Debt	n/a	44.77M	4.14M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	124K	n/a	n/a	n/a	55.03M
Total Long-Term Liabilities	31.46M	45.68M	6.09M	2.64M	1.29M	77.93M	55.03M
Total Liabilities	65.36M	60.37M	20.8M	14.27M	11.26M	81.16M	57.42M
Total Debt	46.87M	46.59M	6.78M	3.37M	1.29M	n/a	n/a
Common Stock	6K	6K	4K	2K	2K	1K	1K
Retained Earnings	-387.95M	-285.93M	-214.76M	-147.7M	-91.08M	-34.65M	-14.93M
Comprehensive Income	69K	41K	-205K	18K	2K	5K	-2K
Shareholders Equity	57.83M	140.48M	118.59M	109.27M	158.1M	-33.22M	-13.88M
Total Investments	92.01M	154M	94.95M	88.48M	131.86M	15.53M	7.2M